Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Philip Morris

Tobacco stocks like Altria and Philip Morris International fell slightly on news that the Trump administration was preparing to ban flavored e-cigarettes.

Tobacco Stocks Fall After Trump Threatens Flavored E-Cigarette Ban

Innovative Industrial Properties

Scotts Miracle-Gro

Constellation Brands

Yes, you can generate recurring income from cannabis stocks.

4 Big-Time Dividend Stocks With Marijuana Exposure

Altria Group Inc (NYSE: MO) is in talks with Philip Morris International Inc. (NYSE: PM) for a merger with no premium.

Potential No-Premium Deal Raises Questions On Altria's Outlook, This Analyst Moves Aside

Piper Jaffray lowered its rating of tobacco company Altria to neutral from overweight.

Altria downgraded as analyst questions Philip Morris merger and scrutiny of Juul's vaping ads

AbbVie

Caterpillar

Federal Realty Investment Trust

Walgreens

Exxon Mobil

Investor concerns about a potential recession and bear market are at the highest levels in a decade. The media is constantly hyping the idea that a recession is imminent.

The 7 Best Dividend Aristocrats To Buy With Recession Risk This High

The influence of the electronic cigarette maker's marketing on teens is being investigated.

Juul E-Cigs Face FTC Scrutiny

Altria has been a wonderful company to own in the past.

Altria: The Sinner Discount Is Too High To Pass On

Investing in pot stocks isn't the only way to cash in on the industry's rapid growth.

2 of the Safest Bets in the Cannabis Industry

The tobacco giant has a track record few other businesses can match.

Altria Is Investment Royalty After 50th Straight Years of Dividend Hikes

By New Frontier Data Last week, Altria Group and Philip Morris International (PMI) announced being in discussions for a potential all-stock "merger of equals," signifying a combined $210 billion deal with impacts for one of the Canadian cannabis sector's leading companies.

Altria-PMI Merger Confirms Longtime Predictions, Marks Industry Progression

Smoking alternatives are the future of the tobacco industry and these industry giants.

It's Not Cigarettes Bringing Altria and Philip Morris International Together Again

HSBC Holdings

Simon Property Group

HSBC Holdings PLC, Altria Group Inc., 3M Co. and Simon Property Group Inc. have declined to their respective three-year lows.

Stocks That Fell to 3-Year Lows in the Week of Aug. 30

If Altria and Philip Morris International reunite to become the world's largest tobacco company, it would focus on far more than cigarettes.

Altria and PMI's proposed tobacco merger faces a future with fewer cigarettes, more regulation

Altria Group (NASDAQ: MO) shares were trading over 4% lower Thursday afternoon. FTC investigators are looking at whether Juul is engaged in deceptive marketing, including targeting minors or using influencers, according to a Reuters report.

What Altria's CEO Is Saying About Juul

Altria (MO) reported earnings 30 days ago. What's next for the stock?

Altria (MO) Down 2.6% Since Last Earnings Report: Can It Rebound?

International tobacco sales are finally rolling over, so merging Altria's pot and vaping investments into Philip Morris makes sense.
The post Altria Stock: Give Me Dividends and Give Me Death appeared first on InvestorPlace.

Altria Stock: Give Me Dividends and Give Me Death

British American Tobacco

Turning Point Brands

Universal Corp

With growth prospects and healthy dividend income, there's a tobacco stock that fits well in nearly any investor's portfolio.

5 Top Tobacco Stocks to Buy Now

Altria (MO) is in discussions with Philip Morris to consider the prospects of a merger. The companies have not revealed further information regarding the development.

Altria (MO) in Talks to Unite With Philip Morris, Stock Down

PMI shouldn’t agree to bail out Altria’s ailing domestic business.

4 Reasons Philip Morris International Shouldn't Merge With Altria

It's been more than 10 years since two tobacco giants first broke apart, but the industry has changed and the two are considering joining forces again.

Why Philip Morris and Altria Broke Up and What’s Changed

With Altria’s investment in Juul, a combination of the tobacco giants would dominate the international market for e-cigarettes.

Philip Morris and Altria Are in Talks to Merge

On Tuesday, tobacco giants Altria (MO) and Philip Morris International (PM) announced discussions of a possible merger. The two companies stated that a deal has not yet been reached, but that it is possible and talks are underway.

Altria and Philip Morris International in Merger Talks: What you Need to Know

S&P Global Ratings said there is insufficient information available regarding a potential all-stock merger between of equals between Philip Morris International Inc.

S&P sees 'significant roadblocks' to completing a Philip Morris-Altria merger

Philip Morris and Altria confirmed they were in merger talks on Tuesday, making one or multiple traders millions of dollars, Jon Najarian says.

Someone made millions on the Philip Morris-Altria deal, trader Jon Najarian says

Cigarette maker Philip Morris International Inc. (NYSE: PM) said Tuesday it's in discussions about the possibility of reuniting with industry leader Altria Group, Inc.

News for Altria Stock (MO)